Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy.
A Reghan FoleyPomi YunMeganne E LeachSarah B NeuhausGilberto V AverionYing HuLeslie H HayesSandra DonkervoortMinal S JainMelissa WaiteRebecca ParksDiana X Bharucha-GoebelOscar H MayerYaqun ZouMargaret FinkJameice DeCosterChristopher MendozaCynthia ArévaloRudolf HausmannDiana PetrakiYing-Kuen CheungCarsten G BonnemannPublished in: Neurology. Genetics (2024)
Clinical Trials NCT01805024.